Astrid Eisenkölbl

Pediatric Neurologist and Neuromuscular Specialist

Clinical and research fellow

Email Astrid

Dr. Astrid Eisenkölbl is a pediatric neurologist with specialization in neuromuscular medicine at the Department for Paediatric and Adolescent Medicine at the Kepler University Hospital in Linz, Austria. Astrid will join Dr. Lochmüller‘s for a clinical and research fellowship to deepen her clinical knowledge and gain new insights in neuromuscular research.

Astrid Eisenkolbl profile picture

Read more about Astrid

Recent publications

Weiß, C, Becker, LL, Friese, J, Blaschek, A, Hahn, A, Illsinger, S et al.. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study. Lancet Reg Health Eur. 2024.47 101092 PMID:39434961

Peternell, A, Lechner, C, Breu, M, Preisel, M, Schimmel, M, Eisenkölbl, A et al.. Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2024.50 86-95 PMID:38705015

Schwartz, O, Vill, K, Pfaffenlehner, M, Behrens, M, Weiß, C, Johannsen, J et al.. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial. JAMA Pediatr. 2024.178 (6)540-547 PMID:38587854

Pühringer, M, Eisenkölbl, A, Gröppel, G. Corrigendum to "Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1". Mol Genet Metab Rep. 2024.38 101039 PMID:38469095

Eisenkölbl, A, Pühringer, M. Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies - A Case Report. J Neuromuscul Dis. 2024.11 (2)493-498 PMID:38306058

Pühringer, M, Eisenkölbl, A, Gröppel, G. Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1. Mol Genet Metab Rep. 2024.38 101031 PMID:38077957

Pechmann, A, Behrens, M, Dörnbrack, K, Tassoni, A, Wenzel, F, Stein, S et al.. Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study. J Neuromuscul Dis. 2023.10 (1)29-40 PMID:36565133

Krenn, M, Sener, M, Rath, J, Zulehner, G, Keritam, O, Wagner, M et al.. The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study. J Neurol. 2023.270 (2)909-916 PMID:36308527

Pechmann, A, Behrens, M, Dörnbrack, K, Tassoni, A, Wenzel, F, Stein, S et al.. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study. Orphanet J Rare Dis. 2022.17 (1)384 PMID:36274155

Wendel, EM, Thonke, HS, Bertolini, A, Baumann, M, Blaschek, A, Merkenschlager, A et al.. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome. Neurol Neuroimmunol Neuroinflamm. 2022.9 (6) PMID:36229191

See more on PubMed